SEC Company Response from Meihua International Medical Technologies Co., (MHUAF) — Feb 24, 2026
Meihua International Medical Technologies Co., Ltd.
Date: Feb. 24, 2026 · CIK: 0001835615 · Accession: 0001213900-26-019927
AI Filing Summary & Sentiment
File numbers found in text: 333-293682
Show Raw Text
CORRESP 1 filename1.htm Meihua International Medical Technologies Co., Ltd. 88 Tongda Road, Touqiao Town, Guangling District Yangzhou, China, 225000 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C., 20549 Attention: Nicholas O'Leary February 24, 2026 Re: Meihua International Medical Technologies Co., Ltd. Registration Statement on Form F-3 (File No. 333-293682) Filed on February 24, 2026 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Meihua International Medical Technologies Co., Ltd. hereby requests acceleration of effectiveness of the above referenced Registration Statement, so that it will become effective at 5:00 p.m., Eastern Time, on February 25, 2026, or as soon as thereafter practicable. Very truly yours, /s/ Leyi Lee Name: Leyi Lee Title: Chief Executive Officer cc: Joan Wu, Esq. Hunter Taubman Fischer & Li LLC